Singapore markets open in 7 hours 29 minutes

Sorrento Therapeutics, Inc. (SRNE)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.02000.0000 (0.00%)
As of 01:12PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
60,321
62,839
52,904
39,986
Cost of revenue
22,867
33,452
13,031
9,940
Gross profit
37,454
29,387
39,873
30,046
Operating expenses
Research development
239,317
221,226
206,922
111,340
Selling general and administrative
197,553
182,337
196,856
116,179
Total operating expenses
441,101
407,888
407,918
231,572
Operating income or loss
-403,647
-378,501
-368,045
-201,526
Interest expense
9,297
8,574
10,224
20,157
Total other income/expenses net
-116,372
-174,672
-84,259
-88,897
Income before tax
-529,316
-561,747
-462,528
-310,580
Income tax expense
-33,657
-2,416
-33,516
-2,014
Income from continuing operations
-495,505
-577,757
-429,138
-314,410
Net income
-493,568
-572,843
-428,325
-298,461
Net income available to common shareholders
-493,568
-572,843
-428,325
-298,461
Basic EPS
-1.10
-1.37
-1.45
-1.30
Diluted EPS
-1.10
-1.37
-1.45
-1.30
Basic average shares
507,859
419,315
294,774
229,823
Diluted average shares
507,859
419,315
294,774
229,823